CNE100002XK2
CNE100002XK2
ZHEJIANG AUSUN PHARMACEUTICAL C
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 792.759.012 | 795.288.309 | 0.3% |
| Cost of Revenue | 368.562.171 | 363.980.824 | 1.3% |
| Gross Profit | 424.196.841 | 431.307.485 | 1.6% |
| 285.570.949 | 225.438.666 | 26.7% | |
| Operating Income | 138.625.892 | 205.868.819 | 32.7% |
| Pretax Income | 137.903.857 | 240.200.049 | 42.6% |
| Net Income Common Stockholders | 130.570.124 | 206.791.017 | 36.9% |
| -- | -- | -- | |
| -- | -- | -- |